Arvin Capital Management LP Bio Techne Corp Call Options Transaction History
Arvin Capital Management LP
- $477 Million
- Q3 2025
Call Options
1 transactions
Others Institutions Holding TECH
# of Institutions
651Shares Held
162MCall Options Held
514KPut Options Held
347K-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$890 Million0.02% of portfolio
-
Morgan Stanley New York, NY7.24MShares$430 Million0.03% of portfolio
-
State Street Corp Boston, MA5.75MShares$342 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.12MShares$304 Million0.05% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.33B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...